Please use this identifier to cite or link to this item:
|Scopus||Web of Science®||Altmetric|
|Title:||An update on stem cell therapies for acute coronary syndrome|
|Citation:||Current Cardiology Reports, 2014; 16(9):526-538|
|Publisher:||Current Medicine Group|
|Peter J. Psaltis, Daniel B. Spoon, Dennis T. L. Wong, Rajiv Gulati|
|Abstract:||Well into the second decade since its conception, cell transplantation continues to undergo intensive evaluation for the treatment of myocardial infarction. At a mechanistic level, its objectives remain to replace lost cardiac cell mass with new functioning cardiomyocytes and vascular cells, thereby minimizing infarct size and scar formation, and improving clinical outcomes by preventing adverse left ventricular remodeling and recurrent ischemic events. Many different cell types, including pluripotent stem cells and various adult-derived progenitor cells, have been shown to have therapeutic potential in preclinical studies, while early phase human trial experience has provided divergent outcomes and fundamental lessons, emphasizing that there remain key issues to address and challenges to overcome before cell therapy can be applied to wider clinical practice. The purpose of this review is to provide a balanced update on recent seminal developments in this exciting field and look to the next important steps to ensure its forward progression.|
|Keywords:||Humans; Pluripotent Stem Cells; Myocardial Infarction; Treatment Outcome; Mesenchymal Stem Cell Transplantation; Bone Marrow Transplantation; Induced Pluripotent Stem Cells; Acute Coronary Syndrome; Regeneration; Endothelial Progenitor Cells|
|Rights:||© Springer Science+Business Media New York 2014|
|Appears in Collections:||Medicine publications|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.